Skip to main content
Erschienen in: Pediatric Cardiology 2/2024

26.10.2023 | Research

Hypertension: An Important But Reversible Cause of Systolic Dysfunction in a Cohort of Pediatric Patients

verfasst von: Alicia M. Kamsheh, Kevin E. Meyers, Robert A. Palermo, Lezhou Wu, Danielle S. Burstein, Jonathan B. Edelson, Kimberly Y. Lin, Katsuhide Maeda, Joseph W. Rossano, Carol A. Wittlieb-Weber, Matthew J. O’Connor

Erschienen in: Pediatric Cardiology | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

Cardiac dysfunction due to hypertension (CDHTN) in pediatrics is not well described. We aimed to describe the presentation and outcomes of pediatric CDHTN and identify clinical features associated with resolution of dysfunction. A single-center retrospective cohort study of patients ≤ 21 years with CDHTN from January 2005–September 2020 was performed. Patients with systolic dysfunction without another cause, blood pressure > 95th percentile, and physician judgment that dysfunction was secondary to hypertension were included. Demographics, clinical characteristics, echocardiographic findings, and outcomes were examined using Fisher’s exact and Mann–Whitney U tests. Multiple correspondence analysis was used to explore the relationship of resolution of dysfunction to clinical features. Thirty-four patients were analyzed at a median age of 10.9 (IQR 0.3–16.9) years. Patients were divided into groups < 1 year (n = 12) and ≥ 1 year (n = 22). Causes of hypertension were varied by age, with renovascular disease most common in infants (42%) and medical renal disease most common in older patients (77%). Echocardiography demonstrated mild LV dilation (median LV end-diastolic z-score 2.6) and mild LV hypertrophy (median LV mass z-score 2.4). Most patients (81%) had resolution of dysfunction, particularly infants (92%). One patient died and one patient was listed for heart transplant. None required mechanical circulatory support (MCS). No clinical features were statistically associated with resolution of dysfunction. Hypertension is an important but reversible cause of systolic dysfunction in children. Patients are likely to recover with low mortality and low utilization of MCS or transplantation. Further studies are needed to confirm features associated with resolution of dysfunction.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Antoniucci D, Seccareccia F, Menotti A, Dovellini EV, Prati PL, Rovelli F, Fazzini PF (1997) Prevalence and correlates of echocardiographic determined left ventricular hypertrophy in 2318 asymptomatic middle-aged men: the ECCIS project. Epidemiolgia e Clinica della Cardiopatia Ischemica Silente. G Ital Cardiol 27:363–369PubMed Antoniucci D, Seccareccia F, Menotti A, Dovellini EV, Prati PL, Rovelli F, Fazzini PF (1997) Prevalence and correlates of echocardiographic determined left ventricular hypertrophy in 2318 asymptomatic middle-aged men: the ECCIS project. Epidemiolgia e Clinica della Cardiopatia Ischemica Silente. G Ital Cardiol 27:363–369PubMed
2.
Zurück zum Zitat Liebson PR, Grandits G, Prineas R, Dianzumba S, Flack JM, Cutler JA, Grimm R, Stamler J (1993) Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS). Circulation 87:476–486CrossRefPubMed Liebson PR, Grandits G, Prineas R, Dianzumba S, Flack JM, Cutler JA, Grimm R, Stamler J (1993) Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS). Circulation 87:476–486CrossRefPubMed
3.
Zurück zum Zitat Tingleff J, Munch M, Jakobsen TJ, Torp-Pedersen C, Olsen ME, Jensen KH, Jørgensen T, Kirchoff M (1996) Prevalence of left ventricular hypertrophy in a hypertensive population. Eur Heart J 17:143–149CrossRefPubMed Tingleff J, Munch M, Jakobsen TJ, Torp-Pedersen C, Olsen ME, Jensen KH, Jørgensen T, Kirchoff M (1996) Prevalence of left ventricular hypertrophy in a hypertensive population. Eur Heart J 17:143–149CrossRefPubMed
4.
Zurück zum Zitat Verdecchia P, Carini G, Circo A, Dovellini E, Giovannini E, Lombardo M, Solinas P, Gorini M, Maggioni AP (2001) Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study. J Am Coll Cardiol 38:1829–1835CrossRefPubMed Verdecchia P, Carini G, Circo A, Dovellini E, Giovannini E, Lombardo M, Solinas P, Gorini M, Maggioni AP (2001) Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study. J Am Coll Cardiol 38:1829–1835CrossRefPubMed
6.
7.
Zurück zum Zitat Lip G (2000) Hypertensive heart disease: a complex syndrome or a hypertensive cardiomyopathy? Eur Heart J 21:1653–1665CrossRefPubMed Lip G (2000) Hypertensive heart disease: a complex syndrome or a hypertensive cardiomyopathy? Eur Heart J 21:1653–1665CrossRefPubMed
8.
Zurück zum Zitat Song P, Zhang Y, Yu J, Zha M, Zhu Y, Rahimi K, Rudan I (2019) Global prevalence of hypertension in children: a systematic review and meta-analysis. JAMA Pediatr 173:1154–1163CrossRefPubMedPubMedCentral Song P, Zhang Y, Yu J, Zha M, Zhu Y, Rahimi K, Rudan I (2019) Global prevalence of hypertension in children: a systematic review and meta-analysis. JAMA Pediatr 173:1154–1163CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Skalina ME, Kliegman RM, Fanaroff AA (1986) Epidemiology and management of severe symptomatic neonatal hypertension. Am J Perinatol 3:235–239CrossRefPubMed Skalina ME, Kliegman RM, Fanaroff AA (1986) Epidemiology and management of severe symptomatic neonatal hypertension. Am J Perinatol 3:235–239CrossRefPubMed
10.
Zurück zum Zitat Peterson AL, Frommelt PC, Mussatto K (2006) Presentation and echocardiographic markers of neonatal hypertensive cardiomyopathy. Pediatrics 118:e782–e785CrossRefPubMed Peterson AL, Frommelt PC, Mussatto K (2006) Presentation and echocardiographic markers of neonatal hypertensive cardiomyopathy. Pediatrics 118:e782–e785CrossRefPubMed
11.
Zurück zum Zitat McGonigle LF, Beaudry MA, Coe JY (1987) Recovery from neonatal myocardial dysfunction after treatment of acute hypertension. Arch Dis Child 62:614–615CrossRefPubMedPubMedCentral McGonigle LF, Beaudry MA, Coe JY (1987) Recovery from neonatal myocardial dysfunction after treatment of acute hypertension. Arch Dis Child 62:614–615CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Saland JM, Mahony L, Baum M (2001) Perinatal renal ischemia resulting in hypertensive cardiomyopathy. Pediatrics 107:185–186CrossRefPubMed Saland JM, Mahony L, Baum M (2001) Perinatal renal ischemia resulting in hypertensive cardiomyopathy. Pediatrics 107:185–186CrossRefPubMed
13.
Zurück zum Zitat Hawkins KC, Watson A, Rutter N (1995) Neonatal hypertension and cardiac failure. Eur J Pediatr 154:148–149CrossRefPubMed Hawkins KC, Watson A, Rutter N (1995) Neonatal hypertension and cardiac failure. Eur J Pediatr 154:148–149CrossRefPubMed
14.
Zurück zum Zitat McNiece KL, Gupta-Malhotra M, Samuels J, Bell C, Garcia K, Poffenbarger T, Sorof JM, Portman RJ (2007) Left ventricular hypertrophy in hypertensive adolescents. Hypertension 50:392–395CrossRefPubMed McNiece KL, Gupta-Malhotra M, Samuels J, Bell C, Garcia K, Poffenbarger T, Sorof JM, Portman RJ (2007) Left ventricular hypertrophy in hypertensive adolescents. Hypertension 50:392–395CrossRefPubMed
15.
Zurück zum Zitat Agu NC, Redwine KM, Bell C, Garcia KM, Martin DS, Poffenbarger TS, Bricker JT, Portman RJ, Gupta-Malhotra M (2014) Detection of early diastolic alterations by tissue Doppler imaging in untreated childhood-onset essential hypertension. J Am Soc Hypertens 8:303–311CrossRefPubMedPubMedCentral Agu NC, Redwine KM, Bell C, Garcia KM, Martin DS, Poffenbarger TS, Bricker JT, Portman RJ, Gupta-Malhotra M (2014) Detection of early diastolic alterations by tissue Doppler imaging in untreated childhood-onset essential hypertension. J Am Soc Hypertens 8:303–311CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Gupta-Malhotra M, Devereux RB, Dave A, Bell C, Portman R, Milewicz D (2014) Aortic dilatation in children with systemic hypertension. J Am Soc Hypertens 8:239–245CrossRefPubMedPubMedCentral Gupta-Malhotra M, Devereux RB, Dave A, Bell C, Portman R, Milewicz D (2014) Aortic dilatation in children with systemic hypertension. J Am Soc Hypertens 8:239–245CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Hanevold C, Waller J, Daniels S, Portman R, Sorof J (2004) The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry in hypertensive children: a collaborative study of the International Pediatric Hypertension Association. Pediatrics 113:328–333CrossRefPubMed Hanevold C, Waller J, Daniels S, Portman R, Sorof J (2004) The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry in hypertensive children: a collaborative study of the International Pediatric Hypertension Association. Pediatrics 113:328–333CrossRefPubMed
18.
Zurück zum Zitat Tran AH, Flynn JT, Becker RC, Daniels SR, Falkner BE, Ferguson M, Hanevold CD, Hooper SR, Ingelfinger JR, Lande MB (2020) Subclinical systolic and diastolic dysfunction is evident in youth with elevated blood pressure. Hypertension 75:1551–1556CrossRefPubMed Tran AH, Flynn JT, Becker RC, Daniels SR, Falkner BE, Ferguson M, Hanevold CD, Hooper SR, Ingelfinger JR, Lande MB (2020) Subclinical systolic and diastolic dysfunction is evident in youth with elevated blood pressure. Hypertension 75:1551–1556CrossRefPubMed
19.
Zurück zum Zitat Navarini S, Bellsham-Revell H, Chubb H, Gu H, Sinha MD, Simpson JM (2017) Myocardial deformation measured by 3-dimensional speckle tracking in children and adolescents with systemic arterial hypertension. Hypertension 70:1142–1147CrossRefPubMed Navarini S, Bellsham-Revell H, Chubb H, Gu H, Sinha MD, Simpson JM (2017) Myocardial deformation measured by 3-dimensional speckle tracking in children and adolescents with systemic arterial hypertension. Hypertension 70:1142–1147CrossRefPubMed
20.
Zurück zum Zitat Colan SD, Borow KM, Neumann A (1984) Left ventricular end-systolic wall stress-velocity of fiber shortening relation: a load-independent index of myocardial contractility. J Am Coll Cardiol 4:715–724CrossRefPubMed Colan SD, Borow KM, Neumann A (1984) Left ventricular end-systolic wall stress-velocity of fiber shortening relation: a load-independent index of myocardial contractility. J Am Coll Cardiol 4:715–724CrossRefPubMed
21.
Zurück zum Zitat Banerjee A, Brook MM, Klautz RJM, Teitel DF (1994) Nonlinearity of the left ventricular end-systolic wall stress-velocity of fiber shortening relation in young pigs: a potential pitfall in its use as a single-beat index of contractility. J Am Coll Cardiol 23:514–524CrossRefPubMed Banerjee A, Brook MM, Klautz RJM, Teitel DF (1994) Nonlinearity of the left ventricular end-systolic wall stress-velocity of fiber shortening relation in young pigs: a potential pitfall in its use as a single-beat index of contractility. J Am Coll Cardiol 23:514–524CrossRefPubMed
Metadaten
Titel
Hypertension: An Important But Reversible Cause of Systolic Dysfunction in a Cohort of Pediatric Patients
verfasst von
Alicia M. Kamsheh
Kevin E. Meyers
Robert A. Palermo
Lezhou Wu
Danielle S. Burstein
Jonathan B. Edelson
Kimberly Y. Lin
Katsuhide Maeda
Joseph W. Rossano
Carol A. Wittlieb-Weber
Matthew J. O’Connor
Publikationsdatum
26.10.2023
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 2/2024
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-023-03313-8

Weitere Artikel der Ausgabe 2/2024

Pediatric Cardiology 2/2024 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.